Green-synthesized Nanoparticles as Emerging Antidepressant and Anxiolytic Candidates: A Critical Review of Preclinical Evidence and Translational Prospects.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
Abstract e pubblicazione originale
L’abstract è consultabile nella fonte originale. Non viene ripubblicato qui perché non risulta verificata una licenza compatibile.
Leggi nella fonte originale ↗Parole chiave
AnimalsHumansAnti-Anxiety AgentsAntidepressive AgentsNanoparticlesGreen Chemistry TechnologyTranslational Research, BiomedicalDrug Evaluation, PreclinicalAnxiety DisordersAntidepressantAnxiolyticEco-neuropharmacologyGreen-synthesized nanoparticlesNeuroinflammation
Come citare questo studio
Meesala Krishna Murthy, Dibyaranjan Samal. (2026). Green-synthesized Nanoparticles as Emerging Antidepressant and Anxiolytic Candidates: A Critical Review of Preclinical Evidence and Translational Prospects.. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology. DOI: 10.1007/s11481-026-10323-9
Consulta la pubblicazione originale ↗